Wall Street is positive on Ventyx Biosciences Inc (VTYX). On average, analysts give the stock a Buy rating. The average price target is $13.1, which means analysts expect the stock to rise by 61.73% over the next twelve months. That average ranking earns the stock an Analyst Rating of 34, which is better than 34% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating VTYX a Buy today. Find out what this means to you and get the rest of the rankings on VTYX!